DealdocCollaborative R&d, Licensing and Option Agreement • January 29th, 2022 • California
Contract Type FiledJanuary 29th, 2022 JurisdictionCollaborative R&D, licensing and option agreement for XmAb5871 monoclonal antibodies for autoimmune diseases (terminated)